- "What?"... "I CAN - hear what you're saying..."
- A New Year, A New You!
- SPIO workshop by Theraplay@home: Orlando, Florida
- The Sideways Glance...
- Superbrain yoga!
- Thoughts for a New Year: Meat of known origin, revisited
- The "Bull" that is Autism...
- Heart MD Institute: East meets west
- How does nutrition impact early childhood immunity?
- H1N1: From the Ayurvedic perspective
- Signs of the need for detoxification
- Ayurveda: Where medicine meets universal consciousness
- Ghee and its many benefits
- Yogi Cameron's ayurvedic view of the autism spectrum
- Ayurveda: The medicine of balance
- Ginger considered a basic universal medicine
Feds distribute $53 million to fight opioid problem
WASHINGTON (AP) — The Obama administration says it will distribute $53 million to 44 states in an effort to curb opioid abuse.
Singapore urges tests for pregnant women with Zika signs
Singapore on Wednesday urged all pregnant women showing symptoms of fever or rashes to have themselves tested for the Zika virus after the number of cases in the city-state soared to 82. Zika, which has been detected in 58 countries including hardest-hit Brazil, causes only mild symptoms for most people, such as fever and a rash. The health ministry said that "all pregnant women in Singapore with symptoms of Zika -- fever and rash and other symptoms such as red eyes or joint pain" should be tested for infection.
Express Scripts diabetes program aims to cap costs for customers
Express Scripts Holding, the largest U.S. pharmacy benefit manager, said on Wednesday it will implement a program next year that guarantees per-patient spending caps on diabetes drug costs in an effort to limit soaring increases for its customers. U.S. diabetes prescription drug spending increased 14 percent in 2015 and is forecast to rise at an even faster rate this year and next, according to an Express Scripts report. For example, if an employer is expected to incur a 20 percent increase in diabetes drug spending in 2017, Express might set a per person/per year cap of no more than a 10 percent increase for its employees.
Theranos withdraws new Zika test after FDA inspection: WSJ
(Reuters) - Blood-testing firm Theranos Inc withdrew its request for emergency clearance of a Zika-virus blood test after U.S. regulators found the company did not include proper patient safeguards in a study on the test, The Wall Street Journal reported, citing people familiar with the matter. Theranos was not immediately available for comment. The diagnostic test for Zika can detect additional strains of the mosquito-borne virus from blood drops finger-pricked from patients, Theranos CEO Elizabeth Holmes said earlier this month.
Three new cases of local Zika transmission in Florida: officials
The new infections bring the state's total of non-travel-related cases to 46, according to the Florida Department of Health. Only one of Tuesday's three new cases was linked to Miami Beach, which is known to be an active area for local Zika transmission. The department said it believes ongoing transmission is only taking place in parts of Miami Beach and the trendy Miami neighborhood of Wynwood, the site of the first local Zika transmission in the United States.
U.N. defends aid work in Syria after accusations of being too close to government
By Ellen Wulfhorst NEW YORK (Thomson Reuters Foundation) - The United Nations defended its aid funding in Syria on Tuesday after an investigation revealed lucrative contracts were awarded to people close to the nation's President Bashar al-Assad. The U.N.'s Syrian contracts came under fire in British newspaper The Guardian which said aid money has gone to a charity set up by Assad's wife and to groups and businesses under U.S. and European Union sanctions. More than 250,000 people have died and 11 million from a population of 23 million have been forced from their homes in Syria's five-year war which started as an uprising against Assad's rule.
Study finds flaws in criticism of St. Jude cyber security
University of Michigan researchers on Tuesday said their own experiments undermine recent allegations of security flaws in St. Jude Medical Inc's pacemakers and other implantable medical devices. Shares of St. Jude fell 5 percent on Thursday after short-selling firm Muddy Waters and its business partner, cyber security company MedSec Holdings Inc, alleged finding significant security bugs in the company's Merlin@home device for monitoring implanted heart devices. The university said its researchers came "to strikingly different conclusions" after generating the conditions reported by Muddy Waters.
Hospital, hepatitis C outbreak victims reach settlement
BISMARCK, N.D. (AP) — Trinity Health and its hospital in Minot have agreed in principal on a legal settlement with 21 victims of the largest hepatitis C outbreak in recent U.S. history, though Trinity's legal fight with a nursing home where most people were sickened will continue.
Lawyer investigating lead at Indiana housing complex
EAST CHICAGO, Ind. (AP) — An attorney for families in an Indiana public housing complex slated to be demolished because of lead contamination says he's investigating whether public officials knew about the problem and allowed children to be "poisoned."
AstraZeneca to pay $5.52 million to resolve SEC foreign bribery case
The U.S. Securities and Exchange Commission detailed the settlement with the London-based drug company in an order instituting an administrative proceeding arising out of violations of provisions in the Foreign Corrupt Practices Act. AstraZeneca, which cooperated with the probe, neither admitted nor denied wrongdoing.